Alaunos Therapeutics | DEFA14A: Others
Apr 26 16:54 ET
Alaunos Therapeutics | DEF 14A: Definitive information statements
Apr 26 16:51 ET
Alaunos Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Apr 15 17:25 ET
Alaunos Therapeutics | 8-K: Current report
Feb 22 16:49 ET
Alaunos Therapeutics | 8-K: Current report
Feb 20 16:10 ET
Alaunos Therapeutics | 8-K: Current report
Feb 1 12:17 ET
Alaunos Therapeutics | 8-K: Current report
Jan 29 08:48 ET
Alaunos Therapeutics | 8-K: Current report
Jan 22 00:00 ET
Alaunos Therapeutics | 8-K: Current report
Jan 2 00:00 ET
Alaunos Therapeutics | 8-K: Current report
Dec 28, 2023 00:00 ET
Alaunos Therapeutics | 8-K: Current report
Dec 22, 2023 08:00 ET
Alaunos Therapeutics | 8-K: Current report
Nov 15, 2023 07:30 ET
Alaunos Therapeutics | 8-K: Alaunos Therapeutics Announces Third Quarter 2023 Financial Results, Phase 1 Clinical Data and Continued Exploration of Strategic Alternatives
Nov 14, 2023 07:40 ET
Alaunos Therapeutics | 8-K: Current report
Sep 28, 2023 16:01 ET
Alaunos Therapeutics | 8-K: Alaunos Therapeutics Announces Second Quarter 2023 Financial Results, Interim Clinical Data and Exploration of Strategic Alternatives
Aug 14, 2023 16:16 ET
Alaunos Therapeutics | 8-K: Current report
Jul 5, 2023 16:15 ET
Alaunos Therapeutics | 8-K: Current report
Jun 12, 2023 16:15 ET
Alaunos Therapeutics | 8-K: Alaunos Therapeutics Reports First Quarter 2023 Financial Results
May 10, 2023 07:09 ET
Alaunos Therapeutics | DEFA14A: Others
Apr 25, 2023 17:06 ET
Alaunos Therapeutics | DEF 14A: Definitive proxy statements
Apr 25, 2023 17:02 ET
No Data
No Data